Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multilevel Models of Therapeutic Response in the Lungs
NCT02947126Phase 1Completed
- Start
- Jan 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hypertonic saline in cystic fibrosis (CF). Started Jan 2017; status: completed.
02
Drugs
hypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02947126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02947126.